Great Lakes Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,376
| Closed | -$231K | – | 756 |
|
|
2023
Q1 | $231K | Sell |
2,376
-30
| -1% | -$2.92K | ﹤0.01% | 746 |
|
|
2022
Q4 | $249K | Buy |
+2,406
| New | +$249K | 0.01% | 588 |
|
|
2022
Q3 | – | Sell |
-3,195
| Closed | -$265K | – | 649 |
|
|
2022
Q2 | $265K | Sell |
3,195
-2,603
| -45% | -$216K | 0.01% | 597 |
|
|
2022
Q1 | $447K | Sell |
5,798
-3,564
| -38% | -$275K | 0.01% | 542 |
|
|
2021
Q4 | $827K | Sell |
9,362
-58,282
| -86% | -$5.15M | 0.01% | 460 |
|
|
2021
Q3 | $5.23M | Sell |
67,644
-31,483
| -32% | -$2.43M | 0.08% | 259 |
|
|
2021
Q2 | $8.27M | Buy |
99,127
+13,435
| +16% | +$1.12M | 0.12% | 209 |
|
|
2021
Q1 | $6.47M | Buy |
85,692
+19,347
| +29% | +$1.46M | 0.1% | 229 |
|
|
2020
Q4 | $5.82M | Sell |
66,345
-1,268
| -2% | -$111K | 0.11% | 222 |
|
|
2020
Q3 | $5.14M | Buy |
67,613
+14,519
| +27% | +$1.1M | 0.11% | 211 |
|
|
2020
Q2 | $6.55M | Sell |
53,094
-36,392
| -41% | -$4.49M | 0.16% | 158 |
|
|
2020
Q1 | $7.56M | Buy |
+89,486
| New | +$7.56M | 0.22% | 119 |
|
|
2019
Q2 | – | Sell |
-2,504
| Closed | -$222K | – | 534 |
|
|
2019
Q1 | $222K | Buy |
+2,504
| New | +$222K | ﹤0.01% | 543 |
|
|
2018
Q4 | – | Sell |
-2,489
| Closed | -$241K | – | 571 |
|
|
2018
Q3 | $241K | Buy |
+2,489
| New | +$241K | 0.01% | 559 |
|